Cas 1373356-68-3,(4-(1-benzhydrylazetidin-3-yl)-4-hydroxypiperidin-1-yl)(phenyl)methanone

1373356-68-3

Post Buying Request

Basic information

Product Name: (4-(1-benzhydrylazetidin-3-yl)-4-hydroxypiperidin-1-yl)(phenyl)methanone
Synonyms: (4-(1-benzhydrylazetidin-3-yl)-4-hydroxypiperidin-1-yl)(phenyl)methanone
CAS NO:1373356-68-3
Molecular Formula:
Molecular Weight: 426.558
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (4-(1-benzhydrylazetidin-3-yl)-4-hydroxypiperidin-1-yl)(phenyl)methanone(CAS DataBase Reference)
NIST Chemistry Reference: (4-(1-benzhydrylazetidin-3-yl)-4-hydroxypiperidin-1-yl)(phenyl)methanone(1373356-68-3)
EPA Substance Registry System: (4-(1-benzhydrylazetidin-3-yl)-4-hydroxypiperidin-1-yl)(phenyl)methanone(1373356-68-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1373356-68-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1373356-68-3 Suppliers

Recommended suppliers

1373356-68-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1373356-68-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,3,3,5 and 6 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1373356-68:
(9*1)+(8*3)+(7*7)+(6*3)+(5*3)+(4*5)+(3*6)+(2*6)+(1*8)=173
173 % 10 = 3
So 1373356-68-3 is a valid CAS Registry Number.

1373356-68-3Upstream product

1373356-68-3Downstream Products

1373356-68-3Relevant academic research and scientific papers

PIPERIDIN-4-YL-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS

-

Paragraph 0360; 0361, (2013/05/08)

Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (I) as follows: wherein Y, Z, and R are defined herein.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1373356-68-3